These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10318549)

  • 1. Blood products used in the treatment of hemophilia.
    Krasnoff AR; Mangione RA
    Hosp Pharm; 1982 Nov; 17(11):598-9, 602-4. PubMed ID: 10318549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of blood, blood components and blood products.
    Blajchman MA; Shepherd FA; Perrault RA
    Can Med Assoc J; 1979 Jul; 121(1):33-42. PubMed ID: 466591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of treatment with activated prothrombin complex concentrate (FEIBA) on factor VIII-antibody level.
    Lechner K; Nowotny C; Krinninger B; Zegner M; Deutsch E
    Thromb Haemost; 1979 Feb; 40(3):478-85. PubMed ID: 425062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of plasma source on T-lymphocyte subpopulations in hemophiliacs using factor VIII concentrate.
    Cable RG; Hoyer L; Marchesi S; Mukherji B; Morse EE; Saxton P
    N Engl J Med; 1983 Oct; 309(17):1057-8. PubMed ID: 6413860
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of haemorrhages in a haemophiliac with factor-VIII inhibitor (author's transl)].
    Angelkort B; Stürner KH
    Dtsch Med Wochenschr; 1979 Feb; 104(5):182-6. PubMed ID: 759178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exchange transfusion and pulse steroid therapy in a hemophiliac with inhibitor.
    Chuansumrit A; Isarangkura P; Krutvecho T; Hathirat P; Pintadit P
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():139-43. PubMed ID: 2499649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients.
    Prentice CR
    Prog Clin Biol Res; 1984; 150():197-206. PubMed ID: 6431428
    [No Abstract]   [Full Text] [Related]  

  • 9. Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma.
    Muntean W
    Wien Klin Wochenschr; 1984 Nov; 96(22):829-32. PubMed ID: 6442046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoprecipitated factor 8 concentrate.
    Pool JG
    Bibl Haematol; 1970; 34():23-9. PubMed ID: 5436350
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemophilia care in Italy.
    Mannucci PM; Ruggeri ZM
    Thromb Haemost; 1976 Jun; 35(3):531-6. PubMed ID: 989958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophiliac with hemolytic anemia resulting from factor VIII concentrate.
    Soni NS; Patel AR; Vohra RM; Shah PC
    Acta Haematol; 1977; 58(5):294-7. PubMed ID: 413305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate.
    Sultan Y; Brouet JC; Debre P
    N Engl J Med; 1974 Nov; 291(20):1087. PubMed ID: 4414451
    [No Abstract]   [Full Text] [Related]  

  • 14. Management and surveillance of the hemophiliacs at the National Institute of Hematology and Blood Transfusion of Vietnam.
    Bach QT; Colab
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():113-5. PubMed ID: 7886550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of in vivo analysis of injected fibrinogen degradation products and factor VIII in patients with hemophilia A].
    Kätzel R; Kubel M; Scheel H; Wegner H
    Z Gesamte Inn Med; 1978 Aug; 33(15):525-9. PubMed ID: 695793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of corticoids in inhibitor suppression in hemophilia A, in addition to continuing treatment with factor VIII concentrate].
    Aznar JA; Jorquera JI; Marty ML
    Sangre (Barc); 1983; 28(3):265-79. PubMed ID: 6414098
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acquired hemophilia A as a cause of postoperative bleeding].
    Leimkühler K; Bach F; Kobert K; Korth M; Schmidt B; Kulbe C; Gummelt I; Mertzlufft F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 May; 38(5):359-65. PubMed ID: 12712401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.